TRUQAP 200 mg/1 (Capivasertib TABLET, FILM COATED) 200 mg/1

TRUQAP 200 mg is a film-coated tablet containing capivasertib, used for targeted therapy. Learn about its uses, effects, and precautions here.

Strength

200 mg/1

Pack Size

4 BLISTER PACK in 1 CARTON (0310-9501-96) / 16 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRUQAP 200 mg is primarily used in targeted therapy to help manage certain types of cancer. Capivasertib, the active ingredient, works by targeting specific proteins involved in cell growth. This medication is often part of a broader treatment plan, including other therapies. Patients should consult their healthcare provider to understand what is TRUQAP 200 mg used for in their specific case.

Side Effects

Common effects of TRUQAP 200 mg may include fatigue, nausea, and diarrhea. Some users might experience changes in appetite or skin reactions. These effects can vary widely among individuals, and not everyone will experience them. It's important to monitor any side effects and discuss them with a healthcare professional.

Precautions & Warnings

TRUQAP 200 mg should be handled with care, following the prescribed dosage and administration guidelines. It is essential to store the medication properly and keep it out of reach of children. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of TRUQAP 200 mg.

Avoid Interactions

TRUQAP 200 mg may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Patients should discuss all current medications with their healthcare provider to ensure safe use. It's crucial to be aware of potential interactions to prevent adverse effects.

Frequently Asked Questions

TRUQAP 200 mg is used in targeted therapy for certain types of cancer, focusing on proteins involved in cell growth.

TRUQAP 200 mg is taken orally, typically as part of a treatment plan prescribed by a healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and changes in appetite or skin reactions.

Patients should consult their healthcare provider to check for potential interactions with other medications.

TRUQAP 200 mg should be stored according to the instructions provided by the manufacturer, typically at room temperature.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.